LMR Partners’s iShares Biotechnology ETF IBB Stock Holding History

LMR Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,149	Closed	-$194K	–	1631
2026 Q1	$194K	Buy	+1,149	New	+$196K	﹤0.01%	1199
2024 Q4	–	Sell	-33,678	Closed	-$4.9M	–	1382
2024 Q3	$4.9M	Buy	+33,678	New	+$4.87M	0.04%	371
2024 Q1	–	Sell	-76,593	Closed	-$10.4M	–	1223
2023 Q4	$10.4M	Buy	+76,593	New	+$9.35M	0.12%	194
2022 Q3	–	Sell	-85,638	Closed	-$10.1M	–	1254
2022 Q2	$10.1M	Buy	+85,638	New	+$10.2M	0.17%	135
2021 Q4	–	Sell	-25,441	Closed	-$4.11M	–	1201
2021 Q3	$4.11M	Buy	+25,441	New	+$4.28M	0.05%	293
2019 Q3	–	Sell	-69,560	Closed	-$7.59M	–	464
2019 Q2	$7.59M	Buy	+69,560	New	+$7.4M	0.28%	51

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

LMR Partners's IBB Position: Q2 2026 in Review

LMR Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 1,149 shares — an estimated $194K sold.

LMR Partners first reported a position in IBB in Q2 2019 and held it in 6 quarters. The position peaked at $10.4M in Q4 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

LMR Partners reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
LMR Partners sold 1,149 iShares Biotechnology ETF shares in Q2 2026, an estimated $194K.
LMR Partners first reported a position in iShares Biotechnology ETF in Q2 2019 and held it in 6 quarters.
LMR Partners's iShares Biotechnology ETF position peaked at $10.4M in Q4 2023.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.